Search

everythinglearnresearchcommunity

for

Search:↓

Spanish experts provided guidelines for treating skin side effects in cancer patients on new therapies, stressing early action and teamwork.

New androgen receptor modulators show promise for treating diseases like prostate cancer and muscle wasting.

New patents show progress in developing drugs targeting the Wnt pathway for diseases like cancer and hair loss.

Gene therapy shows promise for treating skin disorders and cancer, but faces technical challenges.

The PDGF/PDGFR pathway is a potential drug target with mixed success in treating various diseases, including some cancers and fibrosis.

Dutasteride effectively treats enlarged prostate, reduces prostate cancer risk, and promotes hair regrowth with few side effects.

The document provides advice on how to recognize and treat skin-related side effects of cancer drugs known as EGFR inhibitors.

As of 1994, treatments for liver cancer had not significantly improved patient survival.

The article concludes that hair loss is a common side effect of drugs treating skin cancer by blocking the hedgehog pathway, but treatment should continue, and more selective drugs might prevent this side effect.

Pemetrexed is as effective as docetaxel but has fewer side effects for treating nonsmall-cell lung cancer after EGFR-TKI therapy failure.

Six new genetic regions linked to early hair loss also connect to Parkinson's disease and prostate cancer, possibly leading to new treatments.

Nanotechnology is improving drug delivery and targeting, with promising applications in cancer treatment, gene therapy, and cosmetics, but challenges remain in ensuring precise delivery and safety.

Metformin, a diabetes drug, may also help fight cancer, but more research is needed to understand how.

Different substances that activate or block the androgen receptor can affect male development and treat conditions like prostate cancer.

The meeting discussed medical findings, including benefits of certain treatments for cancer and heart conditions, and highlighted issues like poor adherence to preventive measures and skill gaps among interns.

FGF signaling is a promising target for developing treatments for wounds, metabolic diseases, and cancer.

The document concludes that non-operative treatment for gender dysphoria is safe and effective, and hormone therapy does not increase cancer risk.

Testosterone replacement therapy improves libido, mood, muscle strength, and bone density in men with Testosterone Deficiency Syndrome.

Dehydroepiandrosterone (DHEA) is a prohormone important for producing sex steroids and has potential health benefits.

Liposomal systems show promise for delivering drugs through the skin but face challenges like high costs and stability issues.

Estrogens help reduce skin aging, and SERMs might offer similar benefits without the risks of hormone therapy.

Too much AKR1C3 enzyme causes resistance to finasteride by increasing testosterone.

Eph/ephrin signaling is important for skin cell behavior and could be targeted to treat skin diseases.

Testing for CAG repeat polymorphism in the androgen receptor gene is not currently recommended for managing hypogonadism.

Mutations in certain receptors can cause diseases and offer new treatment options.

Women have a higher risk of blood clots from hormonal factors and need careful treatment, especially during pregnancy.

Some drugs can cause skin and hair color changes, often reversible when the drug is stopped.

Low testosterone in men is a risk factor for a specific heart rhythm issue, and testosterone treatment may help prevent it.

Taking 5-Alpha Reductase Inhibitors before bladder removal surgery might make high-grade bladder tumors less aggressive.

Kalya Research is an AI tool that effectively finds and analyzes alternative medicine literature, saving researchers time.